Literature DB >> 35896944

Sex-specific metabolic risk factors and their trajectories towards the non-alcoholic fatty liver disease incidence.

C Tong1,2, Q Li3, L Kong4, X Ni1,2, A Halengbieke1,2, S Zhang5, Z Wu1,2, L Tao1,2, Y Han3, D Zheng1,2, X Guo1,2, X Yang6,7.   

Abstract

PURPOSE: Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disease. This study examined sex-specific associations between NAFLD and metabolic factors and investigated the trajectory of risk factors.
METHODS: We retrospectively investigated 16,140 individuals from Beijing Health Management Cohort. Univariate and multivariate time-dependent Cox regression analyses were performed to identify independent risk factors for new-onset NAFLD. The trajectory of risk factors was investigated using the latent growth curve model and growth mixture model.
RESULTS: Over a median follow-up of 3.15 years, 2,450 (15.18%) participants developed NAFLD. The risk factors for NAFLD in men were increased body mass index (BMI); waist circumference (WC); triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), haemoglobin (Hb), and serum uric acid (SUA) levels; and platelet (PLT) count and decreased serum creatinine-to-body weight (sCr/bw) and high-density lipoprotein cholesterol (HDL-C) levels. In women, the risk factors were increased BMI, WC, and fasting plasma glucose (FPG), TG, LDL-C, SUA, white blood cell (WBC), and PLT and decreased sCr/bw and HDL-C levels. In addition, BMI, LDL-C, sCr/bw and PLT changing trajectories were associated with NAFLD in men; BMI, WC, TG, LDL-C, SUA and sCr/bw trends was associated with NAFLD risk in women.
CONCLUSIONS: Development of NAFLD is associated with BMI, LDL-C, sCr/bw and PLT changing trajectories in men; BMI, WC, TG, LDL-C, SUA and sCr/bw trends are associated an increased risk of NAFLD in women. Deterioration of metabolic risk factors status can be a predictor of NAFLD many years before its occurrence.
© 2022. The Author(s), under exclusive licence to Italian Society of Endocrinology (SIE).

Entities:  

Keywords:  Latent growth curve model; Liver disease; Longitudinal studies; Risk factors; Trajectory

Year:  2022        PMID: 35896944     DOI: 10.1007/s40618-022-01848-w

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   5.467


  18 in total

1.  Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study.

Authors:  Chengfu Xu; Chaohui Yu; Han Ma; Lei Xu; Min Miao; Youming Li
Journal:  Am J Gastroenterol       Date:  2013-04-09       Impact factor: 10.864

2.  Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.

Authors:  K-C Sung; D-C Seo; S-J Lee; M-Y Lee; S H Wild; C D Byrne
Journal:  Nutr Metab Cardiovasc Dis       Date:  2019-02-07       Impact factor: 4.222

3.  Intraductal papillary neoplasm of the bile duct: Assessment of invasive carcinoma and long-term outcomes using MRI.

Authors:  Sunyoung Lee; Myeong-Jin Kim; Sohee Kim; Dongil Choi; Kee-Taek Jang; Young Nyun Park
Journal:  J Hepatol       Date:  2018-12-14       Impact factor: 25.083

4.  Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.

Authors:  Fasiha Kanwal; Jennifer R Kramer; Srikar Mapakshi; Yamini Natarajan; Maneerat Chayanupatkul; Peter A Richardson; Liang Li; Roxanne Desiderio; Aaron P Thrift; Steven M Asch; Jinna Chu; Hashem B El-Serag
Journal:  Gastroenterology       Date:  2018-08-23       Impact factor: 22.682

5.  Predicting incident fatty liver using simple cardio-metabolic risk factors at baseline.

Authors:  Ki-Chul Sung; Bum-Soo Kim; Yong-Kyun Cho; Dong-Il Park; Sookyoung Woo; Seonwoo Kim; Sarah H Wild; Christopher D Byrne
Journal:  BMC Gastroenterol       Date:  2012-07-06       Impact factor: 3.067

Review 6.  Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.

Authors:  Giovanni Musso; Roberto Gambino; James H Tabibian; Mattias Ekstedt; Stergios Kechagias; Masahide Hamaguchi; Rolf Hultcrantz; Hannes Hagström; Seung Kew Yoon; Phunchai Charatcharoenwitthaya; Jacob George; Francisco Barrera; Svanhildur Hafliðadóttir; Einar Stefan Björnsson; Matthew J Armstrong; Laurence J Hopkins; Xin Gao; Sven Francque; An Verrijken; Yusuf Yilmaz; Keith D Lindor; Michael Charlton; Robin Haring; Markus M Lerch; Rainer Rettig; Henry Völzke; Seungho Ryu; Guolin Li; Linda L Wong; Mariana Machado; Helena Cortez-Pinto; Kohichiroh Yasui; Maurizio Cassader
Journal:  PLoS Med       Date:  2014-07-22       Impact factor: 11.069

7.  Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study.

Authors:  Shukang Wang; Chengqi Zhang; Guang Zhang; Zhongshang Yuan; Yanxun Liu; Lijie Ding; Xiubin Sun; Hongying Jia; Fuzhong Xue
Journal:  BMJ Open       Date:  2016-06-01       Impact factor: 2.692

8.  TMT-Based Quantitative Proteomics Analysis Reveals Airborne PM2.5-Induced Pulmonary Fibrosis.

Authors:  Shan Liu; Wei Zhang; Fang Zhang; Peter Roepstorff; Fuquan Yang; Zhongbing Lu; Wenjun Ding
Journal:  Int J Environ Res Public Health       Date:  2018-12-31       Impact factor: 3.390

9.  Urinary Taurine Excretion and Risk of Late Graft Failure in Renal Transplant Recipients.

Authors:  Adrian Post; M Yusof Said; Antonio W Gomes-Neto; Jennifer van der Krogt; Pim de Blaauw; Stefan P Berger; Johanna M Geleijnse; Karin Borgonjen; Else van den Berg; Harry van Goor; Gerald Rimbach; Ido P Kema; Dimitrios Tsikas; M Rebecca Heiner-Fokkema; Stephan J L Bakker
Journal:  Nutrients       Date:  2019-09-13       Impact factor: 5.717

10.  Changing trajectories of serum uric acid and risk of non-alcoholic fatty liver disease: a prospective cohort study.

Authors:  Zhimin Ma; Chaonan Xu; Xiaoping Kang; Shan Zhang; Haibin Li; Lixin Tao; Deqiang Zheng; Xiuhua Guo; Xinghua Yang
Journal:  J Transl Med       Date:  2020-03-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.